BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND NDRG1, NDR1, 10397, ENSG00000104419, Q92597, RIT42, CMT4D, TARG1, HMSNL, GC4, RTP, TDD5, PROXY1, NMSL, CAP43
61 results:

  • 1. Unleashing the potential of gene signatures as prognostic and predictive tools: A step closer to personalized medicine in hepatocellular carcinoma (HCC).
    Pourbagheri-Sigaroodi A; Fallah F; Bashash D; Karimi A
    Cell Biochem Funct; 2024 Jan; 42(1):e3913. PubMed ID: 38269520
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Integrative analysis of disulfidptosis and immune microenvironment in hepatocellular carcinoma: a putative model and immunotherapeutic strategies.
    Yang T; Liu J; Liu F; Lei J; Chen S; Ma Z; Ke P; Yang Q; Wen J; He Y; Duan J; Zeng X
    Front Immunol; 2023; 14():1294677. PubMed ID: 38235128
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Seven oxidative stress-related genes predict the prognosis of hepatocellular carcinoma.
    Miao C; He X; Chen G; Kahlert UD; Yao C; Shi W; Su D; Hu L; Zhang Z
    Aging (Albany NY); 2023 Dec; 15(24):15050-15063. PubMed ID: 38097352
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. LINC02561 promotes metastasis in HCC via HIF1-α/ndrg1/UPF1 axis.
    Li SN; Li MX; Guo WW; Zhang LR; Ding YH; Wu XJ
    Gene; 2024 Feb; 896():148033. PubMed ID: 38013127
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The integration of machine learning and multi-omics analysis provides a powerful approach to screen aging-related genes and predict prognosis and immunotherapy efficacy in hepatocellular carcinoma.
    Shen J; Gao H; Li B; Huang Y; Shi Y
    Aging (Albany NY); 2023 Jul; 15(14):6848-6864. PubMed ID: 37517087
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Construction and validation of 3-genes hypoxia-related prognostic signature to predict the prognosis and therapeutic response of hepatocellular carcinoma patients.
    Liu Y; Shen B; Huang T; Wang J; Jiang J
    PLoS One; 2023; 18(7):e0288013. PubMed ID: 37406019
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A review on the role of ndrg1 in different cancers.
    Ghafouri-Fard S; Ahmadi Teshnizi S; Hussen BM; Taheri M; Sharifi G
    Mol Biol Rep; 2023 Jul; 50(7):6251-6264. PubMed ID: 37249826
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Construction of a Combined Hypoxia-related Genes Model for Hepatocellular Carcinoma Prognosis.
    Ren L; Pan X; Ning L; Gong D; Huang J; Deng K; Xie L; Zhang Y
    Curr Comput Aided Drug Des; 2023; 19(2):150-161. PubMed ID: 36567292
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Tolerability of Eribulin and correlation between polymorphisms and neuropathy in an unselected population of female patients with metastatic breast cancer: results of the multicenter, single arm, phase IV PAINTER study.
    La Verde N; Damia G; Garrone O; Santini D; Fabi A; Ciccarese M; Generali DG; Nunzi M; Poletto E; Ferraris E; Cretella E; Scandurra G; Meattini I; Bertolini AS; Cavanna L; Collovà E; Romagnoli E; Rulli E; Legramandi L; Guffanti F; Bramati A; Moretti A; Cassano A; Vici P; Torri V; Farina G;
    Breast Cancer Res; 2022 Oct; 24(1):71. PubMed ID: 36307826
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Motion modeling from 4D MR images of liver simulating phantom.
    Kavaluus H; Koivula L; Salli E; Seppälä T; Saarilahti K; Tenhunen M
    J Appl Clin Med Phys; 2022 Jul; 23(7):e13611. PubMed ID: 35413145
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Claudin-2 promotes colorectal cancer growth and metastasis by suppressing ndrg1 transcription.
    Wei M; Zhang Y; Yang X; Ma P; Li Y; Wu Y; Chen X; Deng X; Yang T; Mao X; Qiu L; Meng W; Zhang B; Wang Z; Han J
    Clin Transl Med; 2021 Dec; 11(12):e667. PubMed ID: 34965023
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Immunogenomic Landscape Analysis of Prognostic Immune-Related Genes in Hepatocellular Carcinoma.
    Qin P; Zhang M; Liu X; Dong Z
    J Healthc Eng; 2021; 2021():3761858. PubMed ID: 34745496
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The Significance of the Rapid Turnover Protein Score as a Predictor of the Long-Term Outcomes in Hepatocellular Carcinoma After Hepatic Resection.
    Yanagaki M; Haruki K; Yasuda J; Furukawa K; Onda S; Tsunematsu M; Shirai Y; Gocho T; Taniai T; Hamura R; Ikegami T
    Ann Surg Oncol; 2021 Dec; 28(13):8130-8139. PubMed ID: 34490525
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. MiR-188-3p and miR-133b Suppress Cell Proliferation in Human Hepatocellular Carcinoma via Post-Transcriptional Suppression of ndrg1.
    Luo Z; Fan Y; Liu X; Liu S; Kong X; Ding Z; Li Y; Wei L
    Technol Cancer Res Treat; 2021; 20():15330338211033074. PubMed ID: 34355586
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Single-Cell Transcriptome Analysis Uncovers Intratumoral Heterogeneity and Underlying Mechanisms for Drug Resistance in Hepatobiliary Tumor Organoids.
    Zhao Y; Li ZX; Zhu YJ; Fu J; Zhao XF; Zhang YN; Wang S; Wu JM; Wang KT; Wu R; Sui CJ; Shen SY; Wu X; Wang HY; Gao D; Chen L
    Adv Sci (Weinh); 2021 Jun; 8(11):e2003897. PubMed ID: 34105295
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Transarterial Chemoembolization of Hepatocellular Carcinoma Using Radiopaque Drug-Eluting Embolics: Impact of Embolic Density and Residual Tumor Perfusion on Tumor Recurrence and Survival.
    Ruff C; Artzner C; Syha R; Grosse U; Hoffmann R; Bitzer M; Partovi S; Horger M; Nikolaou K; Grözinger G
    Cardiovasc Intervent Radiol; 2021 Sep; 44(9):1403-1413. PubMed ID: 34021375
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Identification of a five-immune gene model as an independent prognostic factor in hepatocellular carcinoma.
    Chen H; Li Y; Xiao SY; Guo J
    BMC Cancer; 2021 Mar; 21(1):278. PubMed ID: 33726698
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Identification of the atypical cadherin FAT1 as a novel glypican-3 interacting protein in liver cancer cells.
    Meng P; Zhang YF; Zhang W; Chen X; Xu T; Hu S; Liang X; Feng M; Yang X; Ho M
    Sci Rep; 2021 Jan; 11(1):40. PubMed ID: 33420124
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. LINC01419 promotes cell proliferation and metastasis in hepatocellular carcinoma by enhancing ndrg1 promoter activity.
    Dang H; Chen L; Tang P; Cai X; Zhang W; Zhang R; Huang A; Tang H
    Cell Oncol (Dordr); 2020 Oct; 43(5):931-947. PubMed ID: 32557341
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Hypoxia-induced elevated ndrg1 mediates apoptosis through reprograming mitochondrial fission in HCC.
    Guo DD; Xie KF; Luo XJ
    Gene; 2020 May; 741():144552. PubMed ID: 32165297
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.